Repetto, Ombretta;
Lovisa, Federica;
Elia, Caterina;
Enderle, Daniel;
Romanato, Filippo;
Buffardi, Salvatore;
Sala, Alessandra;
Pillon, Marta;
Steffan, Agostino;
Burnelli, Roberta;
Mussolin, Lara;
Mascarin, Maurizio;
De Re, Valli
Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence
Contributor:
Repetto, Ombretta;
Lovisa, Federica;
Elia, Caterina;
Enderle, Daniel;
Romanato, Filippo;
Buffardi, Salvatore;
Sala, Alessandra;
Pillon, Marta;
Steffan, Agostino;
Burnelli, Roberta;
Mussolin, Lara;
Mascarin, Maurizio;
De Re, Valli
Published:
MDPI AG, 2021
Published in:
Diagnostics, 11 (2021) 6, Seite 917
Language:
English
DOI:
10.3390/diagnostics11060917
ISSN:
2075-4418
Origination:
Footnote:
Description:
Exosomes and other small extracellular vesicles (EVs) are potential sources of cancer biomarkers. Plasma-derived EVs have not yet been studied in pediatric Hodgkin lymphoma (HL), for which predictive biomarkers of relapse are greatly needed. In this two-part proteomic study, we used two-dimensional difference gel electrophoresis (2D-DIGE) followed by liquid chromatography–tandem mass spectrometry (LC–MS/MS) to analyze EV proteins of plasma collected at diagnosis from children with nodular sclerosis HL, relapsed or not. EVs isolated using membrane affinity had radii ranging from 20 to 130 nm and contained the programmed cell death 6-interacting (ALIX) and the tumor susceptibility gene 101 (TSG101) proteins, whereas calnexin (CANX) was not detected. 2D-DIGE identified 16 spots as differentially abundant between non-relapsed and relapsed HL (|fold change| ≥ 1.5, p < 0.05). LC–MS/MS identified these spots as 11 unique proteins, including five more abundant in non-relapsed HL (e.g., complement C4b, C4B; fibrinogen γ chain, FGG) and six more abundant in relapsed HL (e.g., transthyretin, TTR). Shotgun LC–MS/MS on pooled EV proteins from non-relapsed HL identified 161 proteins, including 127 already identified in human exosomes (ExoCarta data). This EV cargo included 89 proteins not yet identified in exosomes from healthy plasma. Functional interrogation by the Database for Annotation, Visualization and Integrated Discovery (DAVID) revealed that the EV proteins participate in platelet degranulation and serine-type endopeptidase activity as the most significant Gene Ontology (GO) biological process and molecular function (p < 0.01).